Your browser doesn't support javascript.
loading
Polypharmacy in Psychiatry: An In-depth Examination of Drug-drug Interactions and Treatment Challenges.
Shekho, Devank; Mishra, Ritika; Kamal, Raj; Khurana, Divya; Chauhan, Abhishek; Awasthi, Ankit.
Afiliação
  • Shekho D; Department of Pharmaceutics, ISF College of Pharmacy, Moga 142001, Punjab, India.
  • Mishra R; Department of Pharmaceutics, ISF College of Pharmacy, Moga 142001, Punjab, India.
  • Kamal R; Department of Quality Assurance, ISF College of Pharmacy, Moga 142001, Punjab, India.
  • Khurana D; Department of Quality Assurance, ISF College of Pharmacy, Moga 142001, Punjab, India.
  • Chauhan A; Department of Pharmaceutics, ISF College of Pharmacy, Moga 142001, Punjab, India.
  • Awasthi A; Department of Pharmaceutics, ISF College of Pharmacy, Moga 142001, Punjab, India.
Curr Pharm Des ; 2024 May 24.
Article em En | MEDLINE | ID: mdl-38798217
ABSTRACT
Polypharmacy in psychiatry is an in-depth examination of drug-drug interactions and treatment challenges that explores the intricate landscape of psychiatric polypharmacy, a practice involving the prescription of multiple medications to individuals with mental health disorders. This review is based on the critical aspects of drug-drug interactions and the associated treatment challenges. Psychiatric polypharmacy is motivated by the complexity of mental health conditions, where monotherapy may be insufficient. While it offers potential benefits, the practice raises concerns related to drug interactions that can compromise safety and efficacy. The review delves into the prevalence and clinical indications for psychiatric polypharmacy, thoroughly analyzing drug interactions, treatment challenges, and strategies for mitigation. Real-world case studies illustrate the complexities and outcomes of managing complex medication regimens, while emerging trends in personalized medicine, advancements in psychopharmacology, multidisciplinary approaches, and digital health solutions offer a glimpse into the future of psychiatric polypharmacy. This examination underscores the importance of a patient-centered, evidence-based approach in optimizing psychiatric polypharmacy to achieve therapeutic benefits while minimizing risks.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Curr Pharm Des Assunto da revista: FARMACIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Curr Pharm Des Assunto da revista: FARMACIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia